コンテンツへスキップ
Merck
  • The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain.

The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain.

Neurobiology of disease (2016-10-19)
Richard P Hulse, Robert A R Drake, David O Bates, Lucy F Donaldson
要旨

Neuropathic pain results from neuroplasticity in nociceptive neuronal networks. Here we demonstrate that control of alternative pre-mRNA splicing, through the splice factor serine-arginine splice factor 1 (SRSF1), is integral to the processing of nociceptive information in the spinal cord. Neuropathic pain develops following a partial saphenous nerve ligation injury, at which time SRSF1 is activated in damaged myelinated primary afferent neurons, with minimal found in small diameter (IB

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
モノクロナール抗ニューロフィラメント200 (リン酸化および非リン酸化) マウス宿主抗体, clone N52, ascites fluid
Sigma-Aldrich
SRPIN340, ≥98% (HPLC)